|
Market Closed -
NYSE
16:00:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.9710 USD | -5.73% |
|
-3.86% | -41.86% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart calendar Lineage Cell Therapeutics, Inc.
Upcoming events on Lineage Cell Therapeutics, Inc.
No events available
Past events on Lineage Cell Therapeutics, Inc.
| 2026-08-06 | Earnings release - Q2 2026 | |
| 2026-08-06 | Earnings presentation | 16:30 |
| 2026-07-13 | Information meeting | 16:30 |
| 2026-06-10 | Annual General Meeting | 11:00 |
| 2026-05-12 | Earnings presentation | 16:30 |
| 2026-05-12 | Earnings release - Q1 2026 | |
| 2026-03-05 | Earnings presentation | 16:30 |
| 2026-03-05 | Earnings release - Q4 2025 | |
| 2025-11-06 | Earnings presentation | 16:30 |
| 2025-11-06 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,95 9,70 -7.79% | 9,50 8,25 15.09% | 14,6 9,90 47.01% | 15,2 | 16,8 | 59,7 |
|
EBITDA Million USD | Released Forecast Spread | -24,0 -25,8 6.82% | -20,9 -22,6 7.54% | -35,9 -35,8 -0.32% | -33,6 | -29,4 | -30,7 |
|
EBIT Million USD | Released Forecast Spread | -24,7 -24,5 -1% | -21,5 -22,9 6.1% | -36,6 -33,9 -8.12% | -31,7 | -35,2 | 6,56 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,3 -24,3 4.27% | -18,6 -21,6 13.94% | -68,6 -69,8 1.68% | -22,6 | -34,4 | 8,62 |
|
Net income Million USD | Released Forecast Spread | -21,5 -22,9 6.36% | -18,6 -21,6 13.81% | -63,5 -69,9 9.08% | -22,6 | -34,4 | 8,61 |
|
EPS USD | Released Forecast Spread | -0,12 -0,13 9.43% | -0,09 -0,11 19.41% | -0,28 -0,30 7.55% | -0,06 | -0,13 | 0,03 |
| Announcement Date | 07/03/24 | 10/03/25 | 05/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,87 1,62 76.91% | 1,50 1,72 -12.67% | 2,77 1,47 87.77% | 3,68 2,30 60.37% | 6,61 1,96 237.22% | 1,73 3,08 -43.92% | 1,07 1,54 -30.36% | 1,99 | 10,4 | 1,51 | 1,51 | 1,51 | 1,51 | 1,88 | 1,88 |
|
EBITDA Million USD | Released Forecast Spread | -4,96 -6,66 25.54% | -6,34 -5,83 -8.86% | -19,6 -6,45 -204.02% | -3,61 -5,64 36.03% | -6,36 -6,03 -5.59% | -7,41 -5,42 -36.75% | -8,74 -7,45 -17.26% | -8,56 | -8,73 | -7,70 | -7,76 | -7,91 | -8,05 | -8,12 | -8,18 |
|
EBIT Million USD | Released Forecast Spread | -5,11 -6,52 21.6% | -6,51 -6,68 2.58% | -19,8 -6,71 -194.98% | -3,79 -6,08 37.71% | -6,55 -6,31 -3.7% | -7,59 -6,54 -16.13% | -8,92 -8,03 -11.09% | -8,94 | -5,53 | -8,80 | -8,60 | -8,78 | -8,95 | -9,13 | -9,31 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,25 -6,30 48.43% | -4,14 -5,70 27.37% | -30,4 -5,71 -432.09% | -29,8 -5,43 -448.2% | -4,39 -11,7 62.64% | -4,79 -5,79 17.26% | 1,54 -7,51 120.56% | -8,46 | -6,03 | -8,47 | -8,31 | -8,52 | -8,73 | -8,30 | -8,41 |
|
Net income Million USD | Released Forecast Spread | -3,27 -6,31 48.17% | -4,14 -5,95 30.45% | -30,5 -5,70 -434.13% | -29,8 -5,43 -448.07% | 0,85 -11,8 107.23% | -4,81 -5,79 16.86% | 1,48 -7,53 119.68% | -8,47 | -6,03 | -8,48 | -8,34 | -8,54 | -8,75 | -8,32 | -8,47 |
|
EPS USD | Released Forecast Spread | -0,01 -0,03 68.42% | -0,02 -0,03 26.31% | -0,13 -0,03 -355.02% | -0,13 -0,03 -405.64% | 0,00 -0,05 - | -0,02 -0,02 0% | 0,01 -0,03 135.71% | -0,03 | 0,00 | -0,03 | -0,03 | -0,03 | -0,03 | -0,03 | -0,03 |
| Announcement Date | 10/03/25 | 13/05/25 | 12/08/25 | 06/11/25 | 05/03/26 | 12/05/26 | 06/08/26 | - | - | - | - | - | - | - | - |
| 2026-09-29 |  | Extraordinary General Meeting | 22:00 |
| 2026-09-29 | | Earnings release - Q2 2026 | |
| 2026-10-06 | | Information meeting | |
| 2026-10-06 | | Analyst/Investor Day | 11:00 |
| 2026-10-12 | | Analyst/Investor Day | |
| 2026-10-12 | | Extraordinary General Meeting | 22:00 |
| 2026-10-13 | | Earnings presentation | 22:00 |
| 2026-10-14 | | Analyst/Investor Day | 12:00 |
| 2026-10-20 | | Information meeting | 08:30 |
| 2026-10-20 | | Analyst/Investor Day |
Past sector events for Lineage Cell Therapeutics, Inc.
| Today | | Extraordinary General Meeting | 02:30 |
| Today | | Extraordinary General Meeting | 02:30 |
| 2026-09-24 | | Analyst/Investor Day | 09:00 |
| 2026-09-24 | | Information meeting | 08:00 |
| 2026-09-23 | | Extraordinary General Meeting | 09:00 |
| 2026-09-23 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-09-23 | | Extraordinary General Meeting | 03:00 |
| 2026-09-23 | | Présentation aux Actionnaires / Analystes | 07:30 |
| 2026-09-23 | | Annual General Meeting | 07:30 |
| 2026-09-22 | | Information meeting | 08:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
- Calendar Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
